Crossmark

Safety Issues Related to Pluripotent Stem Cell-Based Therapies: Tumour Risk

Crossref DOI link: https://doi.org/10.1007/978-3-031-41943-0_18

Published Online: 2024-02-20

Published Print: 2023

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hillenius, Sanne https://orcid.org/0000-0002-3743-4297
Montilla-Rojo, Joaquin https://orcid.org/0000-0002-3168-0796
Eleveld, Thomas F. https://orcid.org/0000-0001-8580-4822
Salvatori, Daniela C. F. https://orcid.org/0009-0005-3006-8502
Looijenga, Leendert H. J. https://orcid.org/0000-0002-8146-1911
License Information

Text and Data Mining valid from 2023-01-01

Version of Record valid from 2023-01-01
More Information

Chapter History

First Online: 20 February 2024